Stannous disuccinate for injection
Function and Efficacy
This product is used to prepare radioactive brain contrast agent for intravenous injection
Ingredients
This product is a compound preparation, the main ingredients of which are: 1.0 mg of ethyl cysteine hydrochloride and 50 μg of stannous chloride (SnCl2·2H2O).
Appearance
This product is white freeze-dried block or powder.
Indication
This product is used to prepare technetium [99mTc] stannous dicysteate injection (one-step method). It is mainly used for brain imaging.
Usage and Dosage
Take a bottle (tube) of this product, and under aseptic operation conditions, inject 1-4 ml of fresh sodium pertechnetate injection into the bottle (<100 mci; ≥10 mci/ml), shake thoroughly, let stand at room temperature for 15 minutes after dissolution, and inject intravenously. The single dose for adults is 370-740 MBq (10 mCi-20 mCi), and the maximum injection volume should not exceed 4 ml. Children should reduce the amount as appropriate.
Adverse Reactions
No adverse reactions have been found.
Precautions
1. Pregnant and lactating women are prohibited from using this product. 2. People who are allergic to this product are prohibited from using this product.
Drug Interactions
Not yet clear.
Storage
Seal and store in a dark place below -4℃. Validity period: tentatively 6 months.
Packaging Specification
Each bottle contains 1.0 mg of bis(2-hydroxyethyl) cysteine hydrochloride, 50 μg of stannous chloride (SnCl2.2H2O), and 10 mg of sodium glucoheptanoate.
Manufacturer
Beijing Syncor Star Medicinal Technology Co., Ltd.
-
Founded in:
2000-08-31 -
Address:
Room 605, Building B, Qingya Building, No. 8 Wenhuiyuan North Road, Haidian District, Beijing -
Tax NO.:
911101088011446537 -
Registered Funds:
$500,000 -
Email: